References
- Stenderup A, Pedersen GT. Yeasts of human origin. Acta Pathol Microbiol Scand 1962;54:462-472.
- Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993;37:1962-1965. https://doi.org/10.1128/AAC.37.9.1962
- Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-390. https://doi.org/10.1093/clinids/11.3.379
- Speletas M, Vyzantiadis TA, Kalala F, et al. Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment. Med Mycol 2008;46:259-263. https://doi.org/10.1080/13693780701558969
- Kobayashi T, Miyazaki Y, Yanagihara K, et al. A probable case of aspiration pneumonia caused by Candida glabrata in a non-neutropenic patient with candidemia. Intern Med 2005;44:1191-1194. https://doi.org/10.2169/internalmedicine.44.1191
- Srivastava S, Kleinman G, Manthous CA. Torulopsis pneumonia: a case report and review of the literature. Chest 1996;110:858-861. https://doi.org/10.1378/chest.110.3.858
- Choi HK, Jeong SJ, Lee HS, et al. Blood stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J Intern Med 2009;24:263-269. https://doi.org/10.3904/kjim.2009.24.3.263
- Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12: 80-96.
- Marks MI, Langston C, Eickhoff TC. Torulopsis glabrata: an opportunistic pathogen in man. N Engl J Med 1970; 283:1131-1135. https://doi.org/10.1056/NEJM197011192832103
- Aisner J, Sickles EA, Schimpff SC, Young VM, Greene WH, Wiernik PH. Torulopsis glabrata pneumonitis in patients with cancer: report of three cases. JAMA 1974;230:584-585. https://doi.org/10.1001/jama.1974.03240040054035